COVID-19: PCORI-funded study to assess antimalarial drug’s ability to prevent coronavirus infection

WASHINGTON (April 1, 2020) – The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved up to $50 million to fund a registry and randomized clinical trial of the effectiveness of hydroxychloroquine (HCQ) in preventing COVID-19 infections in U.S. healthcare workers. The registry will create a community of healthcare workers (HCWs) interested in contributing…

Details

Outcomes of coronavirus patients treated with extracorporeal membrane oxygenation in China offers guidance for management of critically ill COVID-19 patients worldwide

April 1, 2020 – The initial experience of extracorporeal membrane oxygenation (ECMO) management for coronavirus 2019 (COVID-19) patients in Shanghai, China provides guidance for management of critically ill COVID-19 patients worldwide, reports a study in the ASAIO Journal. The journal is published in the Lippincott portfolio by Wolters Kluwer. For the most critically ill COVID-19…

Details

Duke to lead $50 million study of COVID-19 prevention in healthcare workers

DURHAM, N.C. — The Patient-Centered Outcomes Research Institute has funded up to $50 million to evaluate hydroxychloroquine (HCQ) as a preventive drug for the novel coronavirus. The funding creates a new rapid-response study designed and led by the Duke Clinical Research Institute (DCRI) which seeks to engage healthcare workers across the nation to understand the…

Details